Form 4 Tracker
Tsveta Milanova

Chief Commercial Officer · 3 filings · Latest: Jun 18, 2026

AGIOS PHARMACEUTICALS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
AGIO
Tsveta MilanovaChief Commercial OfficerApr 2, 2026
Sale
$34.713,262$113.2K46,829
AGIO
Tsveta MilanovaChief Commercial OfficerApr 2, 2026
Option Exercise
$0.008,50050,091
AGIO
Milanova TsvetaApr 2, 2026
Proposed Sale
$34.193,262$111.5K
AGIO
Tsveta MilanovaChief Commercial OfficerMar 2, 2026
Sale
$28.962,868$83.1K41,591
AGIO
Tsveta MilanovaChief Commercial OfficerMar 2, 2026
Option Exercise
$0.009,66642,778
AGIO
Milanova TsvetaMar 2, 2026
Proposed Sale
$30.232,868$86.7K
AGIO
Milanova TsvetaJan 5, 2026
Proposed Sale
$27.222,872$78.2K
AGIO
Milanova TsvetaDec 30, 2025
Proposed Sale
$27.162,932$79.6K
AGIO
Milanova TsvetaJun 24, 2025
Proposed Sale
$34.411,761$60.6K
AGIO
Milanova TsvetaMar 3, 2025
Proposed Sale
$35.541,681$59.7K
AGIO
Milanova TsvetaJan 3, 2025
Proposed Sale
$31.842,804$89.3K